Valeo Pharma Stock Probability of Future Pink Sheet Price Finishing Under 0.0469
| VPHIF Stock | USD 0.05 0.00 0.00% |
Valeo |
Valeo Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Valeo Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Valeo Pharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Valeo Pharma generated a negative expected return over the last 90 days | |
| Valeo Pharma has some characteristics of a very speculative penny stock | |
| Valeo Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 27.75 M. Net Loss for the year was (25.75 M) with profit before overhead, payroll, taxes, and interest of 8.52 M. | |
| Valeo Pharma has accumulated about 27.72 M in cash with (28.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 48.0% of the company outstanding shares are owned by insiders |
Valeo Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Valeo Pink Sheet often depends not only on the future outlook of the current and potential Valeo Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Valeo Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 82.2 M |
Valeo Pharma Technical Analysis
Valeo Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Valeo Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Valeo Pharma. In general, you should focus on analyzing Valeo Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Valeo Pharma Predictive Forecast Models
Valeo Pharma's time-series forecasting models is one of many Valeo Pharma's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Valeo Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Valeo Pharma
Checking the ongoing alerts about Valeo Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Valeo Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Valeo Pharma generated a negative expected return over the last 90 days | |
| Valeo Pharma has some characteristics of a very speculative penny stock | |
| Valeo Pharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 27.75 M. Net Loss for the year was (25.75 M) with profit before overhead, payroll, taxes, and interest of 8.52 M. | |
| Valeo Pharma has accumulated about 27.72 M in cash with (28.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 48.0% of the company outstanding shares are owned by insiders |
Other Information on Investing in Valeo Pink Sheet
Valeo Pharma financial ratios help investors to determine whether Valeo Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Valeo with respect to the benefits of owning Valeo Pharma security.